Prostpalm® (Saw Palmetto for Prostate — BGG)

Serenoa repens
Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Prostpalm® is a standardized saw palmetto extract (Serenoa repens) developed by BGG — distinguished by quality standardization for prostate health applications. Saw palmetto is among the most-recognized and longest-used prostate health botanicals with multiple clinical trials in benign prostatic hyperplasia (BPH). Used for: BPH symptoms, prostate health, urinary flow support.

Studied Dose 320 mg/day saw palmetto (research-validated dose)
Active Compound Saw palmetto fatty acids and sterols (typically 85-95% fatty acids standardization)

Benefits

BPH Symptom Improvement

Saw palmetto extracts shown to improve BPH symptoms in multiple trials — urinary frequency, urgency, weak flow, nocturia, incomplete emptying. Clinical effect modest but well-documented.

Prostate Health Support

Saw palmetto is among the most-used prostate health botanicals globally — long evidence history.

Modest 5-Alpha Reductase Effects

Saw palmetto modestly inhibits 5-alpha reductase — same target as finasteride pharmaceutical (less potent).

Anti-Inflammatory Prostate Effects

Reduces prostate tissue inflammation contributing to BPH symptoms.

Generally Well-Tolerated for Long-Term Use

Excellent safety profile suitable for long-term BPH adjunct use.

Mechanism of action

1

5-Alpha Reductase Inhibition (Modest)

Saw palmetto modestly inhibits both 5α-reductase isoforms — reduces conversion of testosterone to dihydrotestosterone (DHT); same target as finasteride/dutasteride pharmaceuticals (saw palmetto less potent).

2

Anti-Inflammatory Prostate Effects

Reduces inflammatory mediators in prostate tissue.

3

Alpha-Adrenergic Receptor Effects

Some evidence for alpha-adrenergic effects relevant to bladder neck/prostate smooth muscle.

4

Anti-Estrogenic Effects (Modest)

Some modest anti-estrogenic effects relevant to BPH (estrogen contributes to prostate growth).

Clinical trials

1
Saw Palmetto for BPH — Cochrane Reviews

Cochrane evidence reviews of saw palmetto for BPH symptoms.

BPH patients across multiple trials.

Modest improvements in BPH symptoms vs placebo; effect smaller than alpha-blocker pharmaceuticals; well-tolerated.

2
Saw Palmetto STEP Trial

Major clinical trial of saw palmetto vs placebo in BPH.

BPH patients.

No significant benefit vs placebo; one of the negative trials in the saw palmetto literature. Effect size remains debated.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress.
Headache rare.
Allergic reactions rare.
Theoretical bleeding at high doses.

Important Drug interactions

Anticoagulants — modest interactions.
Finasteride / dutasteride — same pharmacological target; theoretical additive 5-AR inhibition; consult.
Hormone-sensitive cancers (prostate, breast) — theoretical concerns; consult oncologist.
Pregnancy — N/A (men's health product).
Pre-surgery — discontinue 1-2 weeks before.

Frequently asked questions about Prostpalm® (Saw Palmetto for Prostate — BGG)

What is Prostpalm?

Prostpalm® is a standardized saw palmetto extract (Serenoa repens) developed by BGG — distinguished by quality standardization for prostate health applications. Saw palmetto is among the most-recognized and longest-used prostate health botanicals with multiple clinical trials in benign prostatic hyperplasia (BPH).

What is Prostpalm used for?

Prostpalm is researched primarily for Men's Health and Prostate Health. Saw palmetto extracts shown to improve BPH symptoms in multiple trials — urinary frequency, urgency, weak flow, nocturia, incomplete emptying. Clinical effect modest but well-documented.

What is the recommended dosage of Prostpalm?

The clinically studied dose is 320 mg/day saw palmetto (research-validated dose) Always follow the product label and check with a healthcare provider for personal advice.

Is Prostpalm safe, and does it have side effects?

For most healthy adults, Prostpalm is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. Mild GI distress. It may also interact with some medications. Prostpalm is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Prostpalm interact with any medications?

Possible interactions include: Anticoagulants — modest interactions. Finasteride / dutasteride — same pharmacological target; theoretical additive 5-AR inhibition; consult. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Prostpalm?

NutraSmarts rates the evidence for Prostpalm as Moderate (3 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Cai T, Cui Y, Yu S, Li Q, Zhou Z, Gao Z Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis Am J Mens Health. 2020;14(2):1557988320905407. doi: 10.1177/1557988320905407.PubMedUsed to support: Systematic review and meta-analysis comparing Serenoa repens to tamsulosin for BPH treatment; backs 'BPH symptom improvement' benefit. Compound/botanical-level evidence; Prostpalm brand not specifically evaluated.
  2. Vela-Navarrete R, Alcaraz A, Rodriguez-Antolin A, et al. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies BJU Int. 2018;122(6):1049-1065. doi: 10.1111/bju.14362.PubMedUsed to support: Systematic review and meta-analysis of RCTs on hexanic Serenoa repens extract (Permixon) for LUTS/BPH; demonstrates significant improvements in urinary symptom scores and flow; backs 'BPH symptom improvement' and 'prostate health support' benefits at the botanical level.
  3. Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ Serenoa repens for benign prostatic hyperplasia Cochrane Database Syst Rev. 2012;12:CD001423. doi: 10.1002/14651858.CD001423.pub3.PubMedUsed to support: Updated Cochrane systematic review of 30 RCTs (5,222 subjects) on Serenoa repens for BPH; concludes it was not superior to placebo on urinary symptom scores in most trials. Included for honest evidence balance; supports 'generally well-tolerated' but not superior efficacy vs placebo in this review.
  4. Franco JV, Trivisonno LF, Sgarbossa N, Alvez GA, Fieiras C, Escobar Liquitay CM, Jung JH Serenoa repens for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement: An Updated Cochrane Review World J Mens Health. 2024;42(3):518-530. doi: 10.5534/wjmh.230222.PubMedUsed to support: Most current (2024) updated Cochrane review on Serenoa repens for LUTS/BPE; provides up-to-date assessment of the full evidence base — backs 'prostate health support' and 'generally well-tolerated for long-term use' claims.